Amgen (AMGN)
(Delayed Data from NSDQ)
$334.30 USD
-1.31 (-0.39%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $336.00 +1.70 (0.51%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Amgen Inc. [AMGN]
Reports for Purchase
Showing records 321 - 340 ( 433 total )
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Lifesciences Review: Down but not out
Provider: HYBRIDAN LLP
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Industry Report ; PHARMA & BIOTECH; This report contains brief updates on the following: VRX, PFE, NVO, MNTA, CORT, BIIB, AMGN. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: ZACKS INVESTMENT RESEARCH